By assessing Gal-3 levels in individuals with established risk factors, such as a family history of pancreatic cancer or genetic predisposition, it may be possible to identify individuals at a higher risk of developing the disease38. The gene discussed is LGALS3; the disease is familial pancreatic carcinoma.